Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression

Cell Cycle

Volumn 15, Issue 2, 2016, Pages 196-212

  Ruijtenberg, Suzan ^a   van den Heuvel, Sander ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

cell cycle; chromatin remodeling; differentiation; proliferation; SWI SNF

Indexed keywords

CYCLIN DEPENDENT KINASE; DIFFERENTIATION INDUCING FACTOR; DIFFERENTIATION INDUCING TRANSCRIPTION FACTOR; DROSOPHILA PROTEIN; DROSOPHILA RBF PROTEIN; PCG PROTEIN; PRB PROTEIN; PROTEIN; PROTEIN MYB; SWITCHING SUCROSE NON FERMENTING PROTEIN; SYNMUVB PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRXG PROTEIN; UNCLASSIFIED DRUG; CHROMATIN; NONHISTONE PROTEIN; SWI-SNF-B CHROMATIN-REMODELING COMPLEX;

CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE SPECIFIC GENE EXPRESSION; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC MODEL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MUSCLE DEVELOPMENT; NERVE CELL DIFFERENTIATION; NONHUMAN; REVIEW; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; CHROMATIN; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION; HUMANS; MUTATION; NEOPLASMS; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84962787230     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1120925     Document Type: Review

References (145)

1. C.Kandoth, M.D.McLellan, F.Vandin, K.Ye, B.Niu, C.Lu, M.Xie, Q.Zhang, J.F.McMichael, M.A.Wyczalkowski, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502:333-9; http://dx.doi.org/10.1038/nature12634
2. M.V.Blagosklonny, A.B.Pardee. The restriction point of the cell cycle. Cell Cycle 2002; 1:103-10
3. S.L.Spencer, S.D.Cappell, F.-C.Tsai, K.W.Overton, C.L.Wang, T.Meyer. The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell 2013; 155:369-83; http://dx.doi.org/10.1016/j.cell.2013.08.062
4. Y.J.Choi, L.Anders. Signaling through cyclin D-dependent kinases. Oncogene 2014; 33:1890-903; http://dx.doi.org/10.1038/onc.2013.137
5. S.Van den Heuvel, N.J.Dyson. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 2008; 9:713-24; http://dx.doi.org/10.1038/nrm2469
6. C.J.Sherr, J.M.Roberts. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12; http://dx.doi.org/10.1101/gad.13.12.1501
7. F.Bassermann, R.Eichner, M.Pagano. The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer. Biochim Biophys Acta 2014; 1843:150-62; http://dx.doi.org/10.1016/j.bbamcr.2013.02.028
8. H.A.Coller, L.Sang, J.M.Roberts. A new description of cellular quiescence. PLoS Biol 2006; 4:e83; http://dx.doi.org/10.1371/journal.pbio.0040083
9. L.Sang, H.A.Coller, J.M.Roberts. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008; 321:1095-100; http://dx.doi.org/10.1126/science.1155998
10. A.Zalc, S.Hayashi, F.Auradé, D.Bröhl, T.Chang, D.Mademtzoglou, P.Mourikis, Z.Yao, Y.Cao, C.Birchmeier, et al. Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest. Dev 2014; 141:2780-90
11. J.Korzelius, I.The, S.Ruijtenberg, M.B.W.Prinsen, V.Portegijs, T.C.Middelkoop, M.J.Groot Koerkamp, F.C.P.Holstege, M.Boxem, S.van den Heuvel. Caenorhabditis elegans cyclin D/CDK4 and cyclin E/CDK2 induce distinct cell cycle re-entry programs in differentiated muscle cells. PLoS Genet 2011; 7:e1002362; http://dx.doi.org/10.1371/journal.pgen.1002362
12. C.L.Mummery, C.E.van den Brink, S.W.de Laat. Commitment to differentiation induced by retinoic acid in P19 embryonal carcinoma cells is cell cycle dependent. Dev Biol 1987; 121:10-9; http://dx.doi.org/10.1016/0012-1606(87)90133-3
13. A.Mac Auley, Z.Werb, P.E.Mirkes. Characterization of the unusually rapid cell cycles during rat gastrulation. Dev 1993; 117:873-83
14. M.A.Ciemerych, P.Sicinski. Cell cycle in mouse development. Oncogene 2005; 24:2877-98; http://dx.doi.org/10.1038/sj.onc.1208608
15. A.A.Filipczyk, A.L.Laslett, C.Mummery, M.F.Pera. Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res 2007; 1:45-60; http://dx.doi.org/10.1016/j.scr.2007.09.002
16. C.Lange, F.Calegari. Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells. Cell Cycle 2010; 9:1893-900; http://dx.doi.org/10.4161/cc.9.10.11598
17. E.Stead, J.White, R.Faast, S.Conn, S.Goldstone, J.Rathjen, U.Dhingra, P.Rathjen, D.Walker, S.Dalton. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 2002; 21:8320-33; http://dx.doi.org/10.1038/sj.onc.1206015
18. A.Calder, I.Roth-Albin, S.Bhatia, C.Pilquil, J.H.Lee, M.Bhatia, M.Levadoux-Martin, J.McNicol, J.Russell, T.Collins, et al. Lengthened G1 phase indicates differentiation status in human embryonic stem cells. Stem Cells Dev 2013; 22:279-95; http://dx.doi.org/10.1089/scd.2012.0168
19. D.Coronado, M.Godet, P.-Y.Bourillot, Y.Tapponnier, A.Bernat, M.Petit, M.Afanassieff, S.Markossian, A.Malashicheva, R.Iacone, et al. A short G1 phase is an intrinsic determinant of naïve embryonic stem cell pluripotency. Stem Cell Res 2013; 10:118-31; http://dx.doi.org/10.1016/j.scr.2012.10.004
20. Y.Sela, N.Molotski, S.Golan, J.Itskovitz-Eldor, Y.Soen. Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein. Stem Cells 2012; 30:1097-108; http://dx.doi.org/10.1002/stem.1078
21. C.Lange, W.B.Huttner, F.Calegari. Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell 2009; 5:320-31; http://dx.doi.org/10.1016/j.stem.2009.05.026
22. F.Calegari, W.B.Huttner. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J Cell Sci 2003; 116:4947-55; http://dx.doi.org/10.1242/jcs.00825
23. S.Pauklin, L.Vallier. The cell-cycle state of stem cells determines cell fate propensity. Cell 2013; 155:135-47; http://dx.doi.org/10.1016/j.cell.2013.08.031
24. P.L.Puri, M.Mercola. BAF60 A, B, and Cs of muscle determination and renewal. Genes Dev 2012; 26:2673-83; http://dx.doi.org/10.1101/gad.207415.112
25. T.Braun, M.Gautel. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol 2011; 12:349-61; http://dx.doi.org/10.1038/nrm3118
26. M.Buckingham, P.W.J.Rigby. Gene regulatory networks and transcriptional mechanisms that control myogenesis. Dev Cell 2014; 28:225-38; http://dx.doi.org/10.1016/j.devcel.2013.12.020
27. H.Weintraub, S.J.Tapscott, R.L.Davis, M.J.Thayer, M.A.Adam, A.B.Lassar, A.D.Miller. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 1989; 86:5434-8; http://dx.doi.org/10.1073/pnas.86.14.5434
28. S.X.Skapek, J.Rhee, D.B.Spicer, A.B.Lassar. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995; 267:1022-4; http://dx.doi.org/10.1126/science.7863328
29. S.S.Rao, C.Chu, D.S.Kohtz. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol 1994; 14:5259-67; http://dx.doi.org/10.1128/MCB.14.8.5259
30. K.Guo, K.Walsh. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J Biol Chem 1997; 272:791-7; http://dx.doi.org/10.1074/jbc.272.2.791
31. J.M.Zhang, X.Zhao, Q.Wei, B.M.Paterson. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J 1999; 18:6983-93; http://dx.doi.org/10.1093/emboj/18.24.6983
32. E.Di Giorgio, E.Gagliostro, A.Clocchiatti, C.Brancolini. The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase. Mol Cell Biol 2015; 35:1633-47; http://dx.doi.org/10.1128/MCB.01461-14
33. J.-B.Lazaro, P.J.Bailey, A.B.Lassar. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev 2002; 16:1792-805; http://dx.doi.org/10.1101/gad.U-9988R
34. M.Kitzmann, M.Vandromme, V.Schaeffer, G.Carnac, J.C.Labbé, N.Lamb, A.Fernandez. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol Cell Biol 1999; 19:3167-76.http://dx.doi.org/10.1128/MCB.19.4.3167
35. E.G.Reynaud, K.Pelpel, M.Guillier, M.P.Leibovitch, S.A.Leibovitch. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts. Mol Cell Biol 1999; 19:7621-9; http://dx.doi.org/10.1128/MCB.19.11.7621
36. L.A.Tintignac, M.P.Leibovitch, M.Kitzmann, A.Fernandez, B.Ducommun, L.Meijer, S.A.Leibovitch. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp Cell Res 2000; 259:300-7; http://dx.doi.org/10.1006/excr.2000.4973
37. A.Song, Q.Wang, M.G.Goebl, M.A.Harrington. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol 1998; 18:4994-9; http://dx.doi.org/10.1128/MCB.18.9.4994
38. K.Singh, M.Cassano, E.Planet, S.Sebastian, S.M.Jang, G.Sohi, H.Faralli, J.Choi, H.-D.Youn, F.J.Dilworth, et al. A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation. Genes Dev 2015; 29:513-25; http://dx.doi.org/10.1101/gad.254532.114
39. C.Dehay, H.Kennedy. Cell-cycle control and cortical development. Nat Rev Neurosci 2007; 8:438-50; http://dx.doi.org/10.1038/nrn2097
40. E.C.Holland. Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2001; 2:120-9; http://dx.doi.org/10.1038/35052535
41. J.T.M.L.Paridaen, W.B.Huttner. Neurogenesis during development of the vertebrate central nervous system. EMBO Rep 2014; 15:351-64; http://dx.doi.org/10.1002/embr.201438447
42. G.Wilkinson, D.Dennis, C.Schuurmans. Proneural genes in neocortical development. Neuroscience 2013; 253:256-73; http://dx.doi.org/10.1016/j.neuroscience.2013.08.029
43. F.Ali, C.Hindley, G.McDowell, R.Deibler, A.Jones, M.Kirschner, F.Guillemot, A.Philpott. Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis. Dev 2011; 138:4267-77
44. C.Hindley, F.Ali, G.McDowell, K.Cheng, A.Jones, F.Guillemot, A.Philpott. Post-translational modification of Ngn2 differentially affects transcription of distinct targets to regulate the balance between progenitor maintenance and differentiation. Dev 2012; 139:1718-23
45. L.J.A.Hardwick, A.Philpott. Nervous decision-making: to divide or differentiate. Trends Genet TIG 2014; 30:254-61; http://dx.doi.org/10.1016/j.tig.2014.04.001
46. C.C.F.Homem, J.A.Knoblich. Drosophila neuroblasts: a model for stem cell biology. Dev 2012; 139:4297-310
47. C.Berger, S.K.Pallavi, M.Prasad, L.S.Shashidhara, G.M.Technau. A critical role for cyclin E in cell fate determination in the central nervous system of Drosophila melanogaster. Nat Cell Biol 2005; 7:56-62; http://dx.doi.org/10.1038/ncb1203
48. C.Berger, R.Kannan, S.Myneni, S.Renner, L.S.Shashidhara, G.M.Technau. Cell cycle independent role of Cyclin E during neural cell fate specification in Drosophila is mediated by its regulation of Prospero function. Dev Biol 2010; 337:415-24; http://dx.doi.org/10.1016/j.ydbio.2009.11.012
49. M.Fujita, H.Takeshita, H.Sawa. Cyclin E and CDK2 repress the terminal differentiation of quiescent cells after asymmetric division in C. elegans. PloS One 2007; 2:e407; http://dx.doi.org/10.1371/journal.pone.0000407
50. J.Jeong, J.M.Verheyden, J.Kimble. Cyclin E and Cdk2 control GLD-1, the mitosis/meiosis decision, and germline stem cells in Caenorhabditis elegans. PLoS Genet 2011; 7:e1001348; http://dx.doi.org/10.1371/journal.pgen.1001348
51. P.M.Fox, V.E.Vought, M.Hanazawa, M.-H.Lee, E.M.Maine, T.Schedl. Cyclin E and CDK-2 regulate proliferative cell fate and cell cycle progression in the C. elegans germline. Dev 2011; 138:2223-34
52. B.Biedermann, J.Wright, M.Senften, I.Kalchhauser, G.Sarathy, M.-H.Lee, R.Ciosk. Translational repression of cyclin E prevents precocious mitosis and embryonic gene activation during C. elegans meiosis. Dev Cell 2009; 17:355-64; http://dx.doi.org/10.1016/j.devcel.2009.08.003
53. J.Zezula, P.Casaccia-Bonnefil, S.A.Ezhevsky, D.J.Osterhout, J.M.Levine, S.F.Dowdy, M.V.Chao, A.Koff. p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2001; 2:27-34; http://dx.doi.org/10.1093/embo-reports/kve008
54. M.Korenjak, A.Brehm. E2F-Rb complexes regulating transcription of genes important for differentiation and development. Curr Opin Genet Dev 2005; 15:520-7; http://dx.doi.org/10.1016/j.gde.2005.07.001
55. A.Iavarone, E.R.King, X.-M.Dai, G.Leone, E.R.Stanley, A.Lasorella. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature 2004; 432:1040-5; http://dx.doi.org/10.1038/nature03068
56. W.Li, G.Wu, Y.Wan. The dual effects of Cdh1/APC in myogenesis. FASEB J 2007; 21:3606-17
57. A.Busanello, C.Battistelli, M.Carbone, C.Mostocotto, R.Maione. MyoD regulates p57kip2 expression by interacting with a distant cis-element and modifying a higher order chromatin structure. Nucleic Acids Res 2012; 40:8266-75; http://dx.doi.org/10.1093/nar/gks619
58. O.Halevy, B.G.Novitch, D.B.Spicer, S.X.Skapek, J.Rhee, G.J.Hannon, D.Beach, A.B.Lassar. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267:1018-21; http://dx.doi.org/10.1126/science.7863327
59. S.B.Parker, G.Eichele, P.Zhang, A.Rawls, A.T.Sands, A.Bradley, E.N.Olson, J.W.Harper, S.J.Elledge. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995; 267:1024-7; http://dx.doi.org/10.1126/science.7863329
60. Y.Cao, Z.Yao, D.Sarkar, M.Lawrence, G.J.Sanchez, M.H.Parker, K.L.MacQuarrie, J.Davison, M.T.Morgan, W.L.Ruzzo, et al. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 2010; 18:662-74; http://dx.doi.org/10.1016/j.devcel.2010.02.014
61. P.Zhang, C.Wong, D.Liu, M.Finegold, J.W.Harper, S.J.Elledge. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev 1999; 13:213-24; http://dx.doi.org/10.1101/gad.13.2.213
62. M.Papetti, S.N.Wontakal, T.Stopka, A.I.Skoultchi. GATA-1 directly regulates p21 gene expression during erythroid differentiation. Cell Cycle 2010; 9:1972-80; http://dx.doi.org/10.4161/cc.9.10.11602
63. M.Siatecka, F.Lohmann, S.Bao, J.J.Bieker. EKLF directly activates the p21WAF1/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation. Mol Cell Biol 2010; 30:2811-22; http://dx.doi.org/10.1128/MCB.01016-09
64. L.Li, H.Vaessin. Pan-neural Prospero terminates cell proliferation during Drosophila neurogenesis. Genes Dev 2000; 14:147-51
65. M.Lacomme, L.Liaubet, F.Pituello, S.Bel-Vialar. NEUROG2 drives cell cycle exit of neuronal precursors by specifically repressing a subset of cyclins acting at the G1 and S phases of the cell cycle. Mol Cell Biol 2012; 32:2596-607; http://dx.doi.org/10.1128/MCB.06745-11
66. T.Chen, S.Y.R.Dent. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet 2014; 15:93-106; http://dx.doi.org/10.1038/nrg3607
67. E.J.Morris, N.J.Dyson. Retinoblastoma protein partners. Adv Cancer Res 2001; 82:1-54; http://dx.doi.org/10.1016/S0065-230X(01)82001-7
68. D.K.Dimova, O.Stevaux, M.V.Frolov, N.J.Dyson. Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev 2003; 17:2308-20; http://dx.doi.org/10.1101/gad.1116703
69. G.M.Gordon, W.Du. Conserved RB functions in development and tumor suppression. Protein Cell 2011; 2:864-78; http://dx.doi.org/10.1007/s13238-011-1117-z
70. S.Sadasivam, J.A.DeCaprio. The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat Rev Cancer 2013; 13:585-95; http://dx.doi.org/10.1038/nrc3556
71. S.Talluri, F.A.Dick. Regulation of transcription and chromatin structure by pRB: here, there and everywhere. Cell Cycle 2012; 11:3189-98; http://dx.doi.org/10.4161/cc.21263
72. R.W.Gunawardena, S.R.Fox, H.Siddiqui, E.S.Knudsen. SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B. J Biol Chem 2007; 282:20116-23; http://dx.doi.org/10.1074/jbc.M701406200
73. M.Cui, D.S.Fay, M.Han. lin-35/Rb Cooperates With the SWI/SNF Complex to Control Caenorhabditis elegans Larval Development. Genetics 2004; 167:1177-85; http://dx.doi.org/10.1534/genetics.103.024554
74. S.Ruijtenberg, S.van den Heuvel. G1/S Inhibitors and the SWI/SNF Complex Control Cell-Cycle Exit during Muscle Differentiation. Cell 2015; 162:300-13; http://dx.doi.org/10.1016/j.cell.2015.06.013
75. K.Staehling-Hampton, P.J.Ciampa, A.Brook, N.Dyson. A genetic screen for modifiers of E2F in Drosophila melanogaster. Genetics 1999; 153:275-87
76. S.J.Nielsen, R.Schneider, U.M.Bauer, A.J.Bannister, A.Morrison, D.O'Carroll, R.Firestein, M.Cleary, T.Jenuwein, R.E.Herrera, et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 2001; 412:561-5; http://dx.doi.org/10.1038/35087620
77. P.Trojer, G.Li, R.J.Sims, A.Vaquero, N.Kalakonda, P.Boccuni, D.Lee, H.Erdjument-Bromage, P.Tempst, S.D.Nimer, et al. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 2007; 129:915-28; http://dx.doi.org/10.1016/j.cell.2007.03.048
78. M.Korenjak, B.Taylor-Harding, U.K.Binné, J.S.Satterlee, O.Stevaux, R.Aasland, H.White-Cooper, N.Dyson, A.Brehm. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 2004; 119:181-93; http://dx.doi.org/10.1016/j.cell.2004.09.034
79. M.M.Harrison, C.J.Ceol, X.Lu, H.R.Horvitz. Some C. elegans class B synthetic multivulva proteins encode a conserved LIN-35 Rb-containing complex distinct from a NuRD-like complex. Proc Natl Acad Sci U S A 2006; 103:16782-7; http://dx.doi.org/10.1073/pnas.0608461103
80. M.M.Harrison, X.Lu, H.R.Horvitz. LIN-61, one of two Caenorhabditis elegans malignant-brain-tumor-repeat-containing proteins, acts with the DRM and NuRD-like protein complexes in vulval development but not in certain other biological processes. Genetics 2007; 176:255-71; http://dx.doi.org/10.1534/genetics.106.069633
81. L.Litovchick, S.Sadasivam, L.Florens, X.Zhu, S.K.Swanson, S.Velmurugan, R.Chen, M.P.Washburn, X.S.Liu, J.A.DeCaprio. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 2007; 26:539-51; http://dx.doi.org/10.1016/j.molcel.2007.04.015
82. P.W.Lewis, E.L.Beall, T.C.Fleischer, D.Georlette, A.J.Link, M.R.Botchan. Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes Dev 2004; 18:2929-40; http://dx.doi.org/10.1101/gad.1255204
83. D.P.Blanchard, D.Georlette, L.Antoszewski, M.R.Botchan. Chromatin reader L(3)mbt requires the Myb-MuvB/DREAM transcriptional regulatory complex for chromosomal recruitment. Proc Natl Acad Sci U S A 2014; 111:E4234-43; http://dx.doi.org/10.1073/pnas.1416321111
84. M.Boxem, S.van den Heuvel. C. elegans class B synthetic multivulva genes act in G(1) regulation. Curr Biol CB 2002; 12:906-11; http://dx.doi.org/10.1016/S0960-9822(02)00844-8
85. L.N.Petrella, W.Wang, C.A.Spike, A.Rechtsteiner, V.Reinke, S.Strome. synMuv B proteins antagonize germline fate in the intestine and ensure C. elegans survival. Dev 2011; 138:1069-79
86. D.K.Dimova, N.J.Dyson. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005; 24:2810-26; http://dx.doi.org/10.1038/sj.onc.1208612
87. B.Schuettengruber, D.Chourrout, M.Vervoort, B.Leblanc, G.Cavalli. Genome regulation by polycomb and trithorax proteins. Cell 2007; 128:735-45; http://dx.doi.org/10.1016/j.cell.2007.02.009
88. B.Schuettengruber, A.-M.Martinez, N.Iovino, G.Cavalli. Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol 2011; 12:799-814; http://dx.doi.org/10.1038/nrm3230
89. A.Laugesen, K.Helin. Chromatin Repressive Complexes in Stem Cells, Development, and Cancer. Cell Stem Cell 2014; 14:735-51; http://dx.doi.org/10.1016/j.stem.2014.05.006
90. J.Müller, C.M.Hart, N.J.Francis, M.L.Vargas, A.Sengupta, B.Wild, E.L.Miller, M.B.O'Connor, R.E.Kingston, J.A.Simon. Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 2002; 111:197-208; http://dx.doi.org/10.1016/S0092-8674(02)00976-5
91. S.Efroni, R.Duttagupta, J.Cheng, H.Dehghani, D.J.Hoeppner, C.Dash, D.P.Bazett-Jones, S.Le Grice, R.D.G.McKay, K.H.Buetow, et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008; 2:437-47; PMID:18462694; http://dx.doi.org/10.1016/j.stem.2008.03.021
92. B.E.Bernstein, T.S.Mikkelsen, X.Xie, M.Kamal, D.J.Huebert, J.Cuff, B.Fry, A.Meissner, M.Wernig, K.Plath, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-26; PMID:16630819; http://dx.doi.org/10.1016/j.cell.2006.02.041
93. P.Voigt, W.-W.Tee, D.Reinberg. A double take on bivalent promoters. Genes Dev 2013; 27:1318-38; PMID:23788621; http://dx.doi.org/10.1101/gad.219626.113
94. J.J.Jacobs, K.Kieboom, S.Marino, R.A.DePinho, M.van Lohuizen. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397:164-8; PMID:9923679; http://dx.doi.org/10.1038/16476
95. A.-M.Martinez, G.Cavalli. The role of Polycomb Group Proteins in Cell Cycle Regulation During Development. Cell Cycle 2014; 5:1189-97; http://dx.doi.org/10.4161/cc.5.11.2781
96. J.W.Voncken, B.A.J.Roelen, M.Roefs, S.de Vries, E.Verhoeven, S.Marino, J.Deschamps, M.van Lohuizen. Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. Proc Natl Acad Sci U S A 2003; 100:2468-73; PMID:12589020; http://dx.doi.org/10.1073/pnas.0434312100
97. A.P.Bracken, N.Dietrich, D.Pasini, K.H.Hansen, K.Helin. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20:1123-36; PMID:16618801; http://dx.doi.org/10.1101/gad.381706
98. T.S.Mikkelsen, M.Ku, D.B.Jaffe, B.Issac, E.Lieberman, G.Giannoukos, P.Alvarez, W.Brockman, T.-K.Kim, R.P.Koche, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448:553-60; PMID:17603471; http://dx.doi.org/10.1038/nature06008
99. Y.Hirabayashi, N.Suzki, M.Tsuboi, T.A.Endo, T.Toyoda, J.Shinga, H.Koseki, M.Vidal, Y.Gotoh. Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition. Neuron 2009; 63:600-13; PMID:19755104; http://dx.doi.org/10.1016/j.neuron.2009.08.021
100. D.A.Lim, Y.-C.Huang, T.Swigut, A.L.Mirick, J.M.Garcia-Verdugo, J.Wysocka, P.Ernst, A.Alvarez-Buylla. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 2009; 458:529-33; PMID:19212323; http://dx.doi.org/10.1038/nature07726
101. G.Caretti, M.Di Padova, B.Micales, G.E.Lyons, V.Sartorelli. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18:2627-38; PMID:15520282; http://dx.doi.org/10.1101/gad.1241904
102. A.Blais, C.J.C.van Oevelen, R.Margueron, D.Acosta-Alvear, B.D.Dynlacht. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. J Cell Biol 2007; 179:1399-412; PMID:18166651; http://dx.doi.org/10.1083/jcb.200705051
103. P.Asp, R.Blum, V.Vethantham, F.Parisi, M.Micsinai, J.Cheng, C.Bowman, Y.Kluger, B.D.Dynlacht. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci U S A 2011; 108:E149-58; PMID:21551099; http://dx.doi.org/10.1073/pnas.1102223108
104. T.Patel, B.Tursun, D.P.Rahe, O.Hobert. Removal of Polycomb repressive complex 2 makes C. elegans germ cells susceptible to direct conversion into specific somatic cell types. Cell Rep 2012; 2:1178-86; PMID:23103163; http://dx.doi.org/10.1016/j.celrep.2012.09.020
105. C.Kadoch, D.C.Hargreaves, C.Hodges, L.Elias, L.Ho, J.Ranish, G.R.Crabtree. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 2013; 45:592-601; PMID:23644491; http://dx.doi.org/10.1038/ng.2628
106. X.Wang, J.R.Haswell, C.W.M.Roberts. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer–mechanisms and potential therapeutic insights. Clin Cancer Res 2014; 20:21-7; http://dx.doi.org/10.1158/1078-0432.CCR-13-0280
107. B.G.Wilson, C.W.M.Roberts. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011; 11:481-92; PMID:21654818; http://dx.doi.org/10.1038/nrc3068
108. F.C.Holstege, E.G.Jennings, J.J.Wyrick, T.I.Lee, C.J.Hengartner, M.R.Green, T.R.Golub, E.S.Lander, R.A.Young. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 1998; 95:717-28; PMID:9845373; http://dx.doi.org/10.1016/S0092-8674(00)81641-4
109. M.L.Phelan, S.Sif, G.J.Narlikar, R.E.Kingston. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 1999; 3:247-53; PMID:10078207; http://dx.doi.org/10.1016/S1097-2765(00)80315-9
110. J.Lessard, J.I.Wu, J.A.Ranish, M.Wan, M.M.Winslow, B.T.Staahl, H.Wu, R.Aebersold, I.A.Graef, G.R.Crabtree. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 2007; 55:201-15; PMID:17640523; http://dx.doi.org/10.1016/j.neuron.2007.06.019
111. H.Lickert, J.K.Takeuchi, I.Von Both, J.R.Walls, F.McAuliffe, S.L.Adamson, R.M.Henkelman, J.L.Wrana, J.Rossant, B.G.Bruneau. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004; 432:107-12; PMID:15525990; http://dx.doi.org/10.1038/nature03071
112. I.L.De la Serna, Y.Ohkawa, C.A.Berkes, D.A.Bergstrom, C.S.Dacwag, S.J.Tapscott, A.N.Imbalzano. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol Cell Biol 2005; 25:3997-4009; PMID:15870273; http://dx.doi.org/10.1128/MCB.25.10.3997-4009.2005
113. S.V.Forcales, S.Albini, L.Giordani, B.Malecova, L.Cignolo, A.Chernov, P.Coutinho, V.Saccone, S.Consalvi, R.Williams, et al. Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complex. EMBO J 2012; 31:301-16; PMID:22068056; http://dx.doi.org/10.1038/emboj.2011.391
114. S.K.Kia, M.M.Gorski, S.Giannakopoulos, C.P.Verrijzer. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol Cell Biol 2008; 28:3457-64; PMID:18332116; http://dx.doi.org/10.1128/MCB.02019-07
115. B.G.Wilson, X.Wang, X.Shen, E.S.McKenna, M.E.Lemieux, Y.-J.Cho, E.C.Koellhoffer, S.L.Pomeroy, S.H.Orkin, C.W.M.Roberts. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 2010; 18:316-28; PMID:20951942; http://dx.doi.org/10.1016/j.ccr.2010.09.006
116. Y.Kuwahara, A.Charboneau, E.S.Knudsen, B.E.Weissman. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Cancer Res 2010; 70:1854-65; PMID:20179200; http://dx.doi.org/10.1158/0008-5472.CAN-09-1922
117. Y.Kuwahara, D.Wei, J.Durand, B.E.Weissman. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Mol Cancer Res MCR 2013; 11:251-60; PMID:23364536; http://dx.doi.org/10.1158/1541-7786.MCR-12-0390
118. H.Inoue, S.Giannakopoulos, C.N.Parkhurst, T.Matsumura, E.A.Kono, T.Furukawa, N.Tanese. Target genes of the largest human SWI/SNF complex subunit control cell growth. Biochem J 2011; 434:83-92; PMID:21118156; http://dx.doi.org/10.1042/BJ20101358
119. E.Eroglu, T.R.Burkard, Y.Jiang, N.Saini, C.C.F.Homem, H.Reichert, J.A.Knoblich. SWI/SNF complex prevents lineage reversion and induces temporal patterning in neural stem cells. Cell 2014; 156:1259-73; PMID:24630726; http://dx.doi.org/10.1016/j.cell.2014.01.053
120. C.G.Riedel, R.H.Dowen, G.F.Lourenco, N.V.Kirienko, T.Heimbucher, J.A.West, S.K.Bowman, R.E.Kingston, A.Dillin, J.M.Asara, et al. DAF-16 employs the chromatin remodeller SWI/SNF to promote stress resistance and longevity. Nat Cell Biol 2013; 15:491-501; PMID:23604319; http://dx.doi.org/10.1038/ncb2720
121. H.S.Zhang, M.Gavin, A.Dahiya, A.A.Postigo, D.Ma, R.X.Luo, J.W.Harbour, D.C.Dean. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000; 101:79-89; PMID:10778858; http://dx.doi.org/10.1016/S0092-8674(00)80625-X
122. S.Flowers, N.G.Nagl, G.R.Beck, E.Moran. Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. J Biol Chem 2009; 284:10067-75; PMID:19144648; http://dx.doi.org/10.1074/jbc.M808782200
123. S.E.Wirt, A.S.Adler, V.Gebala, J.M.Weimann, B.E.Schaffer, L.A.SaddicL a, P.Viatour, H.Vogel, H.Y.Chang, A.Meissner, et al. G1 arrest and differentiation can occur independently of Rb family function. J Cell Biol 2010; 191:809-25; PMID:21059851; http://dx.doi.org/10.1083/jcb.201003048
124. Y.Tateishi, A.Matsumoto, T.Kanie, E.Hara, K.Nakayama, K.I.Nakayama. Development of mice without Cip/Kip CDK inhibitors. Biochem Biophys Res Commun 2012; 427:285-92; PMID:23000166; http://dx.doi.org/10.1016/j.bbrc.2012.09.041
125. R.Jaenisch, R.Young. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008; 132:567-82; PMID:18295576; http://dx.doi.org/10.1016/j.cell.2008.01.015
126. C.Sage, M.Huang, K.Karimi, G.Gutierrez, M.A.Vollrath, D.-S.Zhang, J.García-Añoveros, P.W.Hinds, J.T.Corwin, D.P.Corey, et al. Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein. Science 2005; 307:1114-8; PMID:15653467; http://dx.doi.org/10.1126/science.1106642
127. I.Ajioka, R.A.P.MartinsR a P, I.T.Bayazitov, S.Donovan, D.A.JohnsonD a, S.Frase, S.A.CiceroS a, K.Boyd, S.S.Zakharenko, M.A.DyerM a. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 2007; 131:378-90; PMID:17956737; http://dx.doi.org/10.1016/j.cell.2007.09.036
128. L.A.Buttitta, A.J.Katzaroff, C.L.Perez, A.de la Cruz, B.A.Edgar. A double-assurance mechanism controls cell cycle exit upoN-terminal differentiation in Drosophila. Dev Cell 2007; 12:631-43; PMID:17419999; http://dx.doi.org/10.1016/j.devcel.2007.02.020
129. L.A.ButtittaL a, A.J.Katzaroff, B.A.EdgarB a. A robust cell cycle control mechanism limits E2F-induced proliferation of terminally differentiated cells in vivo. J Cell Biol 2010; 189:981-96; PMID:20548101; http://dx.doi.org/10.1083/jcb.200910006
130. E.R.Porrello, A.I.Mahmoud, E.Simpson, J.A.Hill, J.A.Richardson, E.N.Olson, H.A.Sadek. Transient Regenerative Potential of the Neonatal Mouse Heart. Science 2011; 331:1078-80; PMID:21350179; http://dx.doi.org/10.1126/science.1200708
131. A.I.Mahmoud, F.Kocabas, S.A.Muralidhar, W.Kimura, A.S.Koura, S.Thet, E.R.Porrello, H.A.Sadek. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 2013; 497:249-53; PMID:23594737; http://dx.doi.org/10.1038/nature12054
132. S.Rampalli, L.Li, E.Mak, K.Ge, M.Brand, S.J.Tapscott, F.J.Dilworth. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 2007; 14:1150-6; PMID:18026121; http://dx.doi.org/10.1038/nsmb1316
133. D.Hanahan, R.A.Weinberg. Hallmarks of cancer: The next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
134. M.Adachi, M.F.Roussel, K.Havenith, C.J.Sherr. Features of macrophage differentiation induced by p19INK4d, a specific inhibitor of cyclin D-dependent kinases. Blood 1997; 90:126-37; PMID:9207446
135. O.Kranenburg, V.Scharnhorst, A.J.Van der Eb, A.Zantema. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J Cell Biol 1995; 131:227-34; PMID:7559779; http://dx.doi.org/10.1083/jcb.131.1.227
136. I.Matushansky, F.Radparvar, A.I.Skoultchi. Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1. Proc Natl Acad Sci U S A 2000; 97:14317-22; PMID:11114185; http://dx.doi.org/10.1073/pnas.250488697
137. F.Rosenbauer, D.G.Tenen. Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 2007; 7:105-17; PMID:17259967; http://dx.doi.org/10.1038/nri2024
138. M.Koppens, M.van Lohuizen. Context-dependent actions of Polycomb repressors in cancer. Oncogene 2015. http://www.nature.com.proxy.library.uu.nl/onc/journal/vaop/ncurrent/full/onc2015195a.html; http://dx.doi.org/10.1038/onc.2015.195
139. A.H.Shain, J.R.Pollack. The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers. PLoS ONE 2013; 8:e55119; PMID:23355908; http://dx.doi.org/10.1371/journal.pone.0055119
140. K.H.Kim, C.W.M.Roberts. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Cancer Genet 2014; 207:365-72; PMID:24853101; http://dx.doi.org/10.1016/j.cancergen.2014.04.004
141. D.Alarcon-Vargas, Z.Zhang, B.Agarwal, K.Challagulla, S.Mani, G.V.Kalpana. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006; 25:722-34; PMID:16302003; http://dx.doi.org/10.1038/sj.onc.1209112
142. H.Lünenbürger, C.Lanvers-Kaminsky, B.Lechtape, M.C.Frühwald. Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines. Anticancer Drugs 2010; 21:514-22; PMID:20147838; http://dx.doi.org/10.1097/CAD.0b013e3283375d5c
143. M.E.Smith, V.Cimica, S.Chinni, S.Jana, W.Koba, Z.Yang, E.Fine, D.Zagzag, C.Montagna, G.V.Kalpana. Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1. Proc Natl Acad Sci U S A 2011; 108:319-24; PMID:21173237; http://dx.doi.org/10.1073/pnas.0913297108
144. M.Tsikitis, Z.Zhang, W.Edelman, D.Zagzag, G.V.Kalpana. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Proc Natl Acad Sci U S A 2005; 102:12129-34; PMID:16099835; http://dx.doi.org/10.1073/pnas.0505300102
145. I.The, S.Ruijtenberg, B.P.Bouchet, A.Cristobal, M.B.W.Prinsen, T.van Mourik, J.Koreth, H.Xu, A.J.R.Heck, A.Akhmanova, et al. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells. Nat Commun 2015; 65906; PMID:25562820; http://www.nature.com/ncomms/2015/150106/ncomms6906/full/ncomms6906.html.